TriSalus Life Sciences, Inc. revenue breakdown overview

TriSalus Life Sciences, Inc. revenue for the last year amounted to 29.43 M USD, the most of which — 29.43 M USD — came from its highest performing source at the moment, Innovative Drug Delivery Technology and Immune-oncology Therapeutics, the year earlier bringing 18.51 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought TriSalus Life Sciences, Inc. 29.43 M USD, and the year before that — 18.51 M USD.